Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia

被引：0
|
作者：
Qian, S. [1 ]
Li, J. [1 ]
Zhang, S. [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7067
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia
    Qian, Si-Xuan
    Li, Jian-Yong
    Tian, Tian
    Shen, Yun-Feng
    Jiang, Yuan-Qiang
    Lu, Hua
    Wu, Han-Xin
    Zhang, Su-Iiang
    Xu, Wei
    [J]. LEUKEMIA RESEARCH, 2007, 31 (10) : 1383 - 1388
  • [2] Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor for elderly patients with previously untreated acute myeloid leukemia
    Suzushima, Hitoshi
    Wada, Naoko
    Yamasaki, Hiroshi
    Eto, Kenichiro
    Shimomura, Taizo
    Kugimiya, Michiko H.
    Horikawa, Kentaro
    Nishimura, Shintaro
    Tsuda, Hiroyuki
    Mitsuya, Hiroaki
    Asou, Norio
    [J]. LEUKEMIA RESEARCH, 2010, 34 (05) : 610 - 614
  • [3] Increasing the dose of aclarubicin in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) can safely and effectively treat relapsed or refractory acute myeloid leukemia
    Liu, Limin
    Zhang, Yanming
    Jin, Zhengming
    Zhang, Xingxia
    Zhao, Guangsheng
    Si, Yejun
    Lin, Guoqiang
    Ma, Aidi
    Sun, Yingxin
    Wang, Li
    Wu, Depei
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (05) : 603 - 608
  • [4] Increasing the dose of aclarubicin in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) can safely and effectively treat relapsed or refractory acute myeloid leukemia
    Limin Liu
    Yanming Zhang
    Zhengming Jin
    Xingxia Zhang
    Guangsheng Zhao
    Yejun Si
    Guoqiang Lin
    Aidi Ma
    Yingxin Sun
    Li Wang
    Depei Wu
    [J]. International Journal of Hematology, 2014, 99 : 603 - 608
  • [5] Low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia
    Jin, Jie
    Chen, Jian
    Suo, Shanshan
    Qian, Wenbin
    Meng, Haitao
    Mai, Wenyuan
    Tong, Hongyan
    Huang, Jian
    Yu, Wenjuan
    Wei, Juyin
    Lou, Yinjun
    [J]. LEUKEMIA & LYMPHOMA, 2015, 56 (06) : 1691 - 1697
  • [6] Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemia
    Qu, Qi
    Liu, Limin
    Zhang, Yanming
    Li, Xiaoli
    Wu, Depei
    [J]. LEUKEMIA RESEARCH, 2015, 39 (12) : 1353 - 1359
  • [7] Decitabine, low-dose cytarabine and aclarubicin combination with granulocyte colony-stimulating factor priming for the induction chemotherapy of older patients with myelodysplastic syndromes and acute myeloid leukemia
    Qian, Sixuan
    Zhang, Run
    Zhu, Yu
    Lu, Hua
    Liu, Peng
    Qiu, Hongxia
    Wu, Hanxin
    Hong, Ming
    Li, Jianyong
    [J]. BLOOD, 2012, 120 (21)
  • [8] The CAG regimen (low-dose cytarabine, aclarubicin hydrochloride and granulocyte colony-stimulating factor) for the treatment of elderly acute myelomonocytic leukaemia: A case study
    Tsuda, T
    Okamoto, Y
    Sakaguchi, R
    Katayama, N
    Ota, K
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2001, 29 (01) : 41 - 47
  • [9] Low-dose homoharringtonine and cytarabine in combination with granulocyte colony-stimulating factor for elderly patients with de novo acute myeloid leukemia
    Chen, Chen
    Xu, Wei
    Yang, Jing
    [J]. LEUKEMIA & LYMPHOMA, 2015, 56 (01) : 141 - 146
  • [10] A low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus a daunorubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia: A propensity score analysis
    Minakata, Daisuke
    Fujiwara, Shin-ichiro
    Ito, Shoko
    Mashima, Kiyomi
    Umino, Kento
    Nakano, Hirofumi
    Kawasaki, Yasufumi
    Sugimoto, Miyuki
    Yamasaki, Ryoko
    Yamamoto, Chihiro
    Ashizawa, Masahiro
    Hatano, Kaoru
    Okazuka, Kiyoshi
    Sato, Kazuya
    Oh, Iekuni
    Ohmine, Ken
    Suzuki, Takahiro
    Muroi, Kazuo
    Kanda, Yoshinobu
    [J]. LEUKEMIA RESEARCH, 2016, 42 : 82 - 87
12345